By Avery Dennison
To get in touch with Avery Dennison, simply fill out the form below.
Subscribe to Supplier
Avery Dennison innovations for more efficient supply chains to feature at LogiPharma 2018
Benoit Jourde, senior business development manager, Intelligent Labels & Healthcare, said that the Avery Dennison stand at Booth 32 (Montreux Convention Centre) will highlight how intelligent labelling can transform efficiency: “We have supply chain game changers at this show, including a number of different applications of smart labelling. They range from Radio Frequency Identification (RFID) labelling through to our TT Sensor Plus™ 2 device, which logs temperatures during shipment.”
Teams from two Avery Dennison divisions will be on hand at the show: Retail Business & Information Solutions (RBIS) and Label & Graphic Materials (LGM). Benoit Jourde said that a round table session will also be facilitated (within the track ‘Mastering Temperature Control & Logistics’) on the theme: How to choose the right components for your passive solutions that will maximize ROI: “Particularly for the pharmaceutical industry, where temperature control is so important, our solutions provide ground-breaking opportunities to increase efficiencies, manage costs, and help ensure supply chain transparency.”
Tim Booth, RFID project manager from Avery Dennison RFID division, said that demonstrations are the best way to get an understanding of the new technologies: “This is a great chance to see intelligent labeling in action, with technologies like RFID and TT Sensor Plus 2 being put through their paces on mobile devices.”
Three main areas will form the focus of the Avery Dennison stand:
Avery Dennison has developed a range of RFID inlays that allow healthcare providers to better manage supply costs and integrity. The solutions combat problems such as tampering, brand counterfeiting, Track & Trace issues, and inventory inaccuracies.
The wireless TT Sensor Plus 2 device (using NFC, combined with Low Energy Bluetooth or RFID) is a cost-effective, intelligent labeling solution around a third the size of a credit card. It not only logs time and temperature, but also offers multiple services such as a cloud environment, an application programming interface and individual calibration capabilities. Data is read using a mobile device, providing outstanding supply chain transparency for producers and purchasers of pharmaceutical temperature-sensitive products.
Avery Dennison’s new range of reinforced insulation panels provide cutting-edge insulation performance for temperature controlled packaging. They insulate up to seven times more effectively than standard materials, saving space, increasing payload and reducing shipping volume.
About Avery Dennison
Avery Dennison (NYSE: AVY) is a global materials science and manufacturing company specializing in the design and manufacture of a wide variety of labeling and functional materials. The company’s products, which are used in nearly every major industry, include pressure-sensitive materials for labels and graphic applications; tapes and other bonding solutions for industrial, medical and retail applications; tags, labels and embellishments for apparel; and radio frequency identification (RFID) solutions serving retail apparel and other markets. Headquartered in Glendale, California, the company employs approximately 30,000 employees in more than 50 countries. Reported sales in 2017 were $6.6 billion. Learn more at www.averydennison.com.
About LogiPharma 2018
The LogiPharma meeting provides an annual networking and thought leadership platform for decision makers in pharma supply chain, logistics, distribution, planning, IT, quality and sourcing to meet and shape the future of their industry.
LogiPharma 2018 is a three-day event, opening April 10 at the Montreux Music & Convention Centre, Switzerland. It will feature some 80 speakers representing supply chain players and leading pharma manufacturers.
The event is expected to attract more than 800 delegates and feature some 120 presentations and discussions. A major theme for the 2018 event will be implications of the EU’s Falsified Medicines Directive and GDP guidelines.
The event is organized by WB Research with more information at: https://LogiPharmaeu.wbresearch.com/.